Apotheka

Apotheka

Early Stage

Making Electronic Medical Records More Secure

Making Electronic Medical Records More Secure

Overview

Raised to Date: Raised: $78,450

Total Commitments ($USD)

Platform

Wefunder

Start Date

01/10/2022

Close Date

08/31/2022

Min. Goal
$100,000
Max. Goal
$4,871,000
Min. Investment

$100

Security Type

Convertible Note

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$10,000,000

Discount

10%

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

09/04/2022

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$337

# of Investors

216

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

High

Capital Intensity

Low

Location

Beverly Hills, California

Business Type

Growth

Apotheka, with a valuation of $10 million, is raising funds on Wefunder. The company has built an electronic medical records platform integrated with blockchain for patient scheduling, registration, point of care, and revenue cycle. The blockchain technology works to make electronic medical records secure and scalable. Apotheka is working as a solution to integrate telemedicine onto the blockchain to facilitate self-assessments of COVID-19 patients. The solution is currently in use at Pacific Stemcells, Health Centurion, and Cedars Sinai TowerENT. Dennis Maliani founded Apotheka in September 2018. The current crowdfunding campaign has a minimum target of $100,000 and a maximum target of $4,871,000. The campaign proceeds will be used for hiring, marketing, customer acquisition, infrastructure, R&D, and technology scaling.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$11,970

$7,494

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-11,533

$-11,908

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$1,364

$7,998

Accounts Receivable

$0

$0

Total Assets

$2,289

$9,493

Short-Term Debt

$0

$0

Long-Term Debt

$84,791

$80,462

Total Liabilities

$84,791

$80,462

Financials as of: 01/10/2022
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
Apotheka 08/31/2022 Wefunder $10,000,000 $78,450 Convertible Note Not Funded RegCF
Apotheka Systems 02/05/2021 Wefunder $6,000,000 $130,918 Equity - Common Funded RegCF
Apotheka Systems 03/17/2020 Fundopolis $10,000,000 $0 Equity - Common Not Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Apotheka on Wefunder 2022
Platform: Wefunder
Security Type: Convertible Note
Valuation: $10,000,000

Follow company

Follow Apotheka on Wefunder 2022

Buy Apotheka's Deal Report

Warning: according to the close date for this deal, Apotheka may no longer be accepting investments.

Apotheka Deal Report

Get KingsCrowd’s comprehensive report on Apotheka including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Apotheka is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Apotheka deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge